Jenex Announces Proposed Debt Settlement
Toronto, Ontario--(Newsfile Corp. - February 13, 2017) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Corporation") announced today that, further to its news release of November 18, 2016, Jenex proposes to issue 34,349,937 common shares in settlement of $1,717,496.93 of debt owed by the Corporation. The common shares are to be issued at a price of $0.05 each and will be subject to a hold period expiring four months plus a day after closing. The debt to be settled includes $600,000 of...
2017-02-13 8:00 AM EST
Jenex Provides Update on Next Generation Technology, TherOZap(TM) to Test Against the West Nile Virus and Zika Virus
Toronto, Ontario--(Newsfile Corp. - January 24, 2017) - The Jenex Corporation (TSXV: JEN.H) ("Jenex", or the "Company"). Jenex would like to report that the development of the working prototype for the patent pending TherOZap™ is progressing well and expected to be completed in 4 to 6 weeks. On December 8 2016, the Company announced the development of its TherOZap™ device utilizing proprietary features would be tested against both the Zika and West Nile Virus. Jenex is now in the final stages...
2017-01-24 9:17 AM EST
Jenex to Test Next Generation Technology, TherOZap(TM) Against the Zika Virus and West Nile Virus
Toronto, Ontario--(Newsfile Corp. - December 8, 2016) - The Jenex Corporation (TSXV: JEN.H) ("Jenex", or the "Company"), Jenex to test next generation technology, TherOZap™, against the Zika Virus and West Nile Virus. Rob Fia, CEO and Chairman of Jenex, reports the Company will undergo testing of its patent pending technology, TherOZap™, against the Zika and West Nile virus. Jenex has engaged an independent lab and internationally recognized health care network to conduct the tests. The tests...
2016-12-08 9:37 AM EST
Jenex Announces TherOZap(TM), the Company's Next Generation Thermal Therapy Insect Device and Proposed Share for Debt Settlement Terms
Toronto, Ontario--(Newsfile Corp. - November 18, 2016) - The Jenex Corporation (TSXV: JEN.H) ( "Jenex", or the "Company"). Jenex announces TherOZap™, the name of the Company's next generation thermal therapy insect device, and debt settlement terms. TherOZap™ will utilize advanced technology to provide relief to sufferers of insect bites and stings. Rob Fia, CEO & Chairman comments: "TherOZap™ will continue to provide the quick relief from pain, itch and stings caused by insect bites that our...
2016-11-18 8:39 AM EST
IIROC Trade Resumption - The Jenex Corporation
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2016) - Trading resumes in: Company: The Jenex Corporation
2016-11-03 9:33 AM EDT
Jenex Signs Exclusive License Agreement with Luminar Media Group Inc. for USD $250,000 for Jenex's Next Generation Thermal Therapy Insect Device
Toronto, Ontario--(Newsfile Corp. - November 3, 2016) - THE JENEX CORPORATION (TSXV: JEN.H) ("Jenex" or the "Corporation"), Rob Fia, CEO and Chairman of Jenex, reports the Corporation has entered into an exclusive license agreement (the "License") with Luminar Media Group Inc. of Aventura, Florida to market Jenex's next generation thermal therapy insect device (the "Device"). Luminar has an extensive contact base with Over the Counter ("OTC") retail distribution channels in the US. Europe and...
2016-11-03 8:00 AM EDT
IIROC Trade Halt - The Jenex Corporation
Vancouver, British Columbia--(Newsfile Corp. - October 31, 2016) - The following issues have been halted by IIROC: Company:
2016-10-31 10:40 AM EDT
Jenex Enters Into Exclusive Product Development Agreement with Microbonds Inc. for Next Generation Thermal Therapy Insect Device
Toronto, Ontario--(Newsfile Corp. - October 18, 2016) - THE JENEX CORPORATION (TSXV: JEN) ("Jenex" or the "Corporation"), Rob Fia, CEO and Chairman of Jenex, reports the Corporation has entered into an exclusive product development agreement with Microbonds Inc. of Markham, Ontario to design Jenex's next generation thermal therapy insect device. Microbonds, is an advanced coatings and electrical design company. Microbonds has worked with many of the largest semiconductor companies in the...
2016-10-18 8:00 AM EDT
Jenex Issues Product Development Update
Toronto, Ontario--(Newsfile Corp. - September 30, 2016) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Company"). Jenex would like to announce the Company has made tangible progress in its product development efforts related to its next generation insect device. Jenex has worked closely with engineering, industrial design and legal experts with a detailed plan to develop a device subject to financing or signing of a licensing contract. The new insect device will provide Jenex with...
2016-09-30 8:29 AM EDT
Jenex Reports Significant Progress with Large Canadian Pharmacy Retailer for Intercept CS with Wide Canadian Retail Network
Toronto, Ontario--(Newsfile Corp. - May 18, 2016) - The Jenex Corporation (NEX: JEN.H) ("Jenex" or the "Company") would like to report that it has made significant progress with a large Canadian Pharmacy Retailer (the "Retailer") with a wide retail network across Canada. The Retailer has requested Point of Purchase ("POP") displays for Jenex's InterceptCS product. The POP displays will be presented to select stores within the Retailer's network to seed the market. If discussions with the...
2016-05-18 9:36 AM EDT
Jenex Announces Appointment of New CEO and Board Changes
Toronto, Ontario--(Newsfile Corp. - February 11, 2016) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Company") announces the appointment of David Duranovich as CEO & Director of the Jenex Corporation. David is a results oriented finance and sales and marketing professional with a track record for revitalizing sales operations, increasing revenues and improving margins. David has a reputation for creating and maintaining strong relationships with high profile Bay St. advisors and...
2016-02-11 8:00 AM EST
IIROC Trade Resumption - The Jenex Corporation
Vancouver, British Columbia--(Newsfile Corp. - December 7, 2015) - Trading resumes in: Company: The Jenex Corporation
2015-12-07 2:32 PM EST
SEC Revokes Registration of The Jenex Corporation Shares
Toronto, Ontario--(Newsfile Corp. - December 7, 2015) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Company"). On December 4, 2016 The Jenex Corporation received notice from the Securities and Exchange Commission ("Commission") that the Commission accepted the Offer of Settlement submitted by the Company for the purposes of settlement of proceedings initiated against Jenex on October 23, 2015, pursuant to Section 12(j) of the Securities Exchange Act of 1934. ("Exchange Act"). The...
2015-12-07 2:26 PM EST
IIROC Trade Halt - The Jenex Corporation
Vancouver, British Columbia--(Newsfile Corp. - December 7, 2015) - The following issues have been halted by IIROC: Company:
2015-12-07 9:22 AM EST
The Jenex Corporation Announces Private Placement
Toronto, Ontario--(Newsfile Corp. - October 9, 2015) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Company") announces that it proposes to raise up to $500,000 from the sale of units (the "Units") at a price of $0.025 each, on a brokered private placement basis. Each Unit will consist of one common share and one-half of one warrant. Each whole warrant is exercisable for one common share during the 12 months following the first closing at an exercise price of $0.05. Proceeds from the...
2015-10-09 4:00 PM EDT
Jenex Announces Closing of Debt Settlement
Toronto, Ontario--(Newsfile Corp. - December 11, 2014) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Corporation") announces that is has completed the debt settlement described in its press release of November 18, 2014. Jenex settled $4,614,472 of secured debt (including accrued interest) by issuing (a) 25,500,000 common shares (b) $600,000 of secured debentures, and (c) 10,000,000 warrants. The terms of the Debentures and the Warrants are described in the November 18, 2014 press...
2014-12-11 5:49 PM EST
Jenex Announces Revised Debt Settlement Terms
Toronto, Ontario--(Newsfile Corp. - November 19, 2014) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Corporation") - Jenex announces revisions to the debt settlement terms set out in its press release of July 9, 2014. Jenex has outstanding debentures and loans (the "Debt") in the total principal amount of $1,275,000. Accrued interest of $3,339,470 was owed on the Debt as of July 31, 2014. Jenex proposes to settle the Debt on the basis that (a) the outstanding principal amount will be...
2014-11-19 8:14 AM EST
Jenex Announces Proposed Debt Settlement
Toronto, Ontario--(Newsfile Corp. - July 9, 2014) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Corporation") Jenex announced today that it proposes to issue common shares and convertible secured debentures in settlement of debt owed by the Corporation. Jenex has outstanding debentures and loans (the "Secured Debt") in the total principal amount of $1,275,000. Accrued interest of $3,007,525 is owed on the Secured Debt. Jenex proposes to settle the Secured Debt on the basis that the...
2014-07-09 11:59 AM EDT
IIROC Trade Resumption - The Jenex Corporation
Vancouver, British Columbia--(Newsfile Corp. - March 6, 2014) - Trading resumes in: Company: The Jenex Corporation
2014-03-06 8:06 AM EST
The Jenex Corporation Update
Toronto, Ontario--(Newsfile Corp. - March 5, 2014) - The common shares of The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Corporation") were formerly listed and posted for trading on the TSX Venture Exchange (the "Exchange"). The Exchange suspended the Corporation's common shares on December 4, 2009 due to cease trade orders in the Provinces of Ontario, Alberta and British Columbia (the "Cease Trade Orders"). being issued against Jenex. The shares of Jenex were subsequently transferred...
2014-03-05 10:44 AM EST